| Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection (NCT05413850) | Blue Earth Therapeutics Ltd | 2022-07-20 |
| EVOLUTION: 177Lu-PSMA Therapy Versus 177Lu-PSMA in Combination With Ipilimumab and Nivolumab for Men With mCRPC (NCT05150236) | Australian and New Zealand Urogenital and Prostate Cancer Trials Group | 2022-04-29 |
| A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer) (NCT05288166) | Eli Lilly and Company | 2022-04-14 |
| Anlotinib Combined With Platinum/Gemcitabine for First Line Treatment of Advanced Urothelial Carcinoma (NCT05030077) | Tianjin Medical University Second Hospital | 2021-10-01 |
| 68Ga-HTK03149 for Use as a Diagnostic Radiopharmaceutical (NCT04831307) | British Columbia Cancer Agency | 2021-08-30 |
| Safety and Efficacy Study of Tislelizumab in Combination With BCG in HR-NMIBC Patients (TACBIN-01) (NCT04922047) | RenJi Hospital | 2021-06-01 |
| Pembrolizumab and Lenvatinib for Platinum- Sensitive Recurrent Ovarian Cancer (NCT04519151) | Sheba Medical Center | 2021-04-12 |
| High Resolution, 18F-PSMA PET-MRI Before Prostate Cancer HIFU or Radical Prostatectomy (NCT04461509) | Alessandro D'Agnolo | 2021-04-06 |
| CTC Quantification During TURBT and PKVBT of Transitional Cell Carcinoma in Purging Fluid and Blood (NCT04811846) | University Teaching Hospital Hall in Tirol | 2021-03-14 |
| Self-Testing Options in the Era of Primary HPV Screening for Cervical Cancer Trial (NCT04679675) | Kaiser Permanente | 2020-11-20 |
| Efficacy and Safety of Niraparib Combined With Bevacizumab in Platinum Refractory/Resistant Recurrent Ovarian Cancer (NCT04556071) | Xiaoxiang Chen | 2020-11-06 |
| Anlotinib Combined With Dose-reduced Olaparib in Patients With Platinum-Sensitive Recurrent Ovarian Cancer (NCT04566952) | Xiaoxiang Chen | 2020-10-28 |
| Trial of NanoPac Focal Therapy for Prostate Cancer (NCT04221828) | NanOlogy, LLC | 2020-10-20 |
| Bintrafusp Alfa (M7824) and PDS01ADC Alone and in Combination With Stereotactic Body Radiation Therapy (SBRT) in Adults With Metastatic Non-Prostate Genitourinary Malignancies (NCT04235777) | National Cancer Institute (NCI) | 2020-07-13 |
| Gender Difference in sidE eFfects of ImmuNotherapy: a Possible Clue to Optimize cancEr tReatment (NCT04435964) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2020-06-25 |
| Individualized Treatment Strategy for Patients With Metastatic Non-clear Cell Renal Cell Carcinoma (NCT04644432) | Herlev and Gentofte Hospital | 2020-03-06 |
| P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC) (NCT04249947) | Poseida Therapeutics, Inc. | 2020-02-28 |
| Evaluation of NanoDoce® in Participants With Urothelial Carcinoma (NCT03636256) | NanOlogy, LLC | 2019-04-02 |
| Potential Therapeutic Response In Urogenital Tumors (NCT03551457) | University of Campinas, Brazil | 2019-01-02 |
| Evaluation of Ocoxin-Viusid® in Advanced or Metastatic Ovarian Epithelial Cancer (NCT03562897) | Catalysis SL | 2018-10-25 |
| Proliposomal Intravesical Paclitaxel for Treatment of Low-Grade, Stage Ta, Non Muscle Invasive Bladder Cancer (NCT03081858) | Lipac Oncology LLC | 2018-05-17 |
| Health Gatherings - For Your Health After Cancer (NCT03344757) | University of Miami | 2017-10-05 |
| A Study of Varlilumab and Atezolizumab in Patients With Advanced Cancer (NCT02543645) | Celldex Therapeutics | 2015-10-01 |
| A Study of Varlilumab (Anti-CD27) and Sunitinib in Patients With Metastatic Clear Cell Renal Cell Carcinoma (NCT02386111) | Celldex Therapeutics | 2015-05-01 |
| A Study Evaluating the Safety, Pharmacokinetics, and Clinical Effects of Intravenously Administered PT-112 Injection in Subjects With Advanced Solid Tumors and Subsequent Dose Expansion Cohorts (NCT02266745) | Promontory Therapeutics Inc. | 2014-07-01 |
| Protection of Rectum From High Radiation Doses Using a Spacer (NCT01918605) | University of Oulu | 2013-06-01 |
| Alkagin Paste in the Prevention of Radiation Dermatitis (NCT01408407) | Sir Mortimer B. Davis - Jewish General Hospital | 2011-12-01 |
| Acupuncture for the Immune System in Radiation Cancer Patients (NCT01422928) | British Columbia Cancer Agency | 2010-12-01 |
| A Study of Ixabepilone Before Surgery for High-Risk Localized Prostate Cancer (NCT00672009) | Cedars-Sinai Medical Center | 2008-04-01 |
| Pharmacokinetic Study on the Administration of Nadroparin Dosing Serum HGF in Gynecological Patients (NCT01523652) | Azienda Ospedaliera San Giovanni Battista | 2007-11-01 |
| A Trial for Patients With Advanced/Recurrent Endometrial Cancer (NCT00377520) | Eli Lilly and Company | 2006-09-01 |
| Glivec in Prostate Cancer Patients With Rising PSA Following Radical Prostectomy (NCT01316458) | Novartis Pharmaceuticals | 2003-06-01 |
| Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer (NCT01217697) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | |
| Study of Motexafin Gadolinium for the Treatment of Renal Cell (Kidney) Cancer (NCT00134186) | Pharmacyclics LLC. | |
| SHTC - EUROPE-1 Synergo Hyperthermia-Chemotherapy by European Urologists' Research Operation Preserving Evolution Study I (NCT02254915) | Medical Enterprises Europe B.V. | |
| Expanded Access to NanoDoce (NCT04060628) | NanOlogy, LLC | |